Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Medtronic Heats CGM Space Up with New FDA Nod
Medical Devices and Diagnostics Industry
Tuesday, April 22, 2025 - 11:01am
tags:
Medtech, Medtronic, CGMs, diabetes, Simplera Sync, FDA
Data readout puts J&J's bladder cancer drug back on track
Pharmaphorum
Tuesday, April 22, 2025 - 11:00am
tags:
JNJ, bladder cancer, TAR-200, clinical trials
Sky Labs' smart ring tops Apple Watch in AFib comparison
Pharmaphorum
Tuesday, April 22, 2025 - 10:58am
tags:
Medtech, Sky Labs, Apple, Apple Watch, atrial fibrillation, wearables, CART-I ring
Novo says it’s submitted obesity pill for FDA approval
BioPharma Dive
Monday, April 21, 2025 - 6:13pm
tags:
Novo Nordisk, Wegovy, obesity, oral Wegovy, FDA
FDA fires most negotiators for pharma user fee talks, sources say
Yahoo/Reuters
Monday, April 21, 2025 - 6:10pm
tags:
FDA, layoffs, drug reviews, user fees
Alector concludes enrollment in Phase II trial of Alzheimer’s treatment
Clinical Trials Arena
Monday, April 21, 2025 - 6:06pm
tags:
clinical trials, Alector, GSK, Alzheimer's disease, AL101
Walgreens to pay $300 million in US opioid settlement
Yahoo/Reuters
Monday, April 21, 2025 - 6:03pm
tags:
Walgreens, legal, pharmacies, opioids, opioid crisis
Dr. Oz sworn in as CMS administrator
Medtech Dive
Monday, April 21, 2025 - 6:02pm
tags:
CMS, Dr Oz, Mehmet Oz
How affirmative action ruling, federal funding cuts impact pharma and biotech
Medical Marketing and Media
Monday, April 21, 2025 - 6:00pm
tags:
pharma industry, biotech, affirmative action
U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich
Stock Titan
Monday, April 21, 2025 - 5:59pm
tags:
legal, Bausch Health, Salix Pharmaceuticals, FDA, Norwich Pharmaceuticals, Xifaxin
Makary Discusses Expedited Rare Disease Approvals Pathway, ‘Public Distrust’ in New Interview
BioSpace
Monday, April 21, 2025 - 5:56pm
tags:
FDA, Marty Makary, Rare Diseases, drug approvals, regulatory
Sanofi, Regeneron win FDA nod for Dupixent in chronic hives
BioPharma Dive
Monday, April 21, 2025 - 11:13am
tags:
Sanofi, Regeneron, Dupixent, FDA, chronic hives
AstraZeneca, Daiichi say Enhertu delivers 'highly statistically significant' efficacy in first-line breast cancer
Fierce Pharma
Monday, April 21, 2025 - 11:12am
tags:
AstraZeneca, Daiichi Sankyo, Enhertu, breast cancer, clinical trials
Trodelvy-Keytruda combo improves cancer trial outcomes
Investing.com
Monday, April 21, 2025 - 11:11am
tags:
Gilead Sciences, Trodelvy, Keytruda, Merck, metastatic triple-negative breast cancer
FDA rejection of extended dosing interval is another piece of bad news for Regeneron’s Eylea HD
Fierce Pharma
Monday, April 21, 2025 - 10:22am
tags:
FDA, Regeneron, Eylea, CRL
FDA moves to block biopharma employees from serving on advisory committees
Fierce Pharma
Monday, April 21, 2025 - 10:11am
tags:
FDA, advisory committees, Marty Makary, regulatory
Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjögren’s Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402
Stock Titan
Monday, April 21, 2025 - 10:09am
tags:
Immunovant, IMVT-1402, Eric Venker
Stealth biotech bags rights to VelaVigo bispecific in $440M deal
Fierce Biotech
Monday, April 21, 2025 - 10:04am
tags:
VelaVigo Bio, Olin Biosciences, bispecific antibodies
FDA cuts outlined in draft HHS budget
BioPharma Dive
Monday, April 21, 2025 - 10:02am
tags:
FDA, layoffs, HHS
A big moment is coming for psychedelics
Pharma Voice
Monday, April 21, 2025 - 10:01am
tags:
COMPASS Pathways, clinical trials, psilocybin, COMP360, clinical depression

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.